Goldman is bracing for a weak first quarter of Foundayo sales, but that isn't the number it thinks will move LLY stock on Aug ...

People with obesity in the United States are being sorted between haves and have-nots. Primary care doctor Ian Huntington has ...

As GLP-1 drug use surges nationwide, overall spending could soon drive up healthcare costs for everyone, according to a new ...

Starting July 1, eligible Medicare Part D beneficiaries will be able to go to the pharmacy and pick up their glucagon-like ...

Many pharmaceutical industry experts had expected that patients would prefer pills over injections, for convenience. Yet eight of 10 doctors said many are opting for the injectables.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...

A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it ...

The top weight-loss drug manufacturers are promoting the new Medicare GLP-1 Bridge as the Trump administration takes a ...

The Senate health committee advanced 13 healthcare bills to the Senate floor, including hospital prices and food regulations.

Healthcare is quietly becoming the value hunter's playground. And two of the largest names look mispriced against their ...

Novo Nordisk accused Eli Lilly of falsely claiming that its weight-loss medicines are more effective, in a U.S. lawsuit, ...

Novo Nordisk claims Eli Lilly aired misleading ads comparing the pharma companies' respective weight-loss drugs, Wegovy and ...